Hyagen Medical Discusses Regulatory Clarity in Stem Cell Therapy

Lehi, UT, Sept. 22, 2026 /CourierPR/ -- Hyagen Medical, a regenerative medicine company dedicated to advancing regulatory clarity, responsible education, and compliance in the human cellular and tissue-based products (HCT/P) sector, recently participated in the PepMed 2026 Regenerative Health World Congress in Washington. Founder and President Chuck Meeker, Ph.D., Esq., was among the notable participants in the event, joining other leaders in the regenerative medicine field for a discussion on regulatory clarity, responsible communication, and the future of stem cell therapy in the United States.

This panel aimed to explore whether the United States could emerge as the leading center for stem cell therapy and to discuss the roles of classification, domestic access, and regulatory understanding in achieving this goal. Hyagen Medical highlighted its commitment to product understanding, regulatory education, clinician training, responsible marketing, patient communication, and clinical implementation in regenerative medicine.

The panel discussion brought together a diverse array of perspectives, including those from science, clinical practice, health care entrepreneurship, patient access, domestic innovation, and regulatory understanding. The event provided a platform for these varied viewpoints to converge and engage in a meaningful dialogue about the future of stem cell therapy in the United States.

For Hyagen Medical, the significance of the Washington conversation was not merely about regulatory oversight. The company's compliance-first philosophy centers around understanding the products clinicians work with and the regulatory responsibilities surrounding them before communicating and administering those products to patients. This approach is integral to Hyagen Medical's work with regenerative medicine practices, encompassing product understanding, regulatory education, clinician training, responsible marketing, patient communication, and clinical implementation.

Hyagen Medical, headquartered in Lehi, Utah, is committed to fostering a more transparent and responsibly informed regenerative medicine marketplace while supporting patient protection and responsible innovation in the United States. The company's media contact information includes Relations and Business Development, 757.621.9319, Press Inquiries, Chuck Meeker, media [at] hyagenmedical.com, 7576219319, and the company's website at www.hyagenmedical.com. Hyagen Medical is located at 1234 Medical Lane, Lehi, Utah 84043. A video accompanying this announcement is available at youtube.com/watch?v=9PhtkAIWRqc.

In summary, Hyagen Medical's participation in the PepMed 2026 Regenerative Health World Congress underscored the company's commitment to regulatory clarity and responsible communication in the field of regenerative medicine. The event provided a platform for diverse perspectives to converge and engage in a meaningful dialogue about the future of stem cell therapy in the United States, with Hyagen Medical's compliance-first philosophy at the heart of its approach to this critical area of regenerative medicine.